Cambio

Cambio is a long-established, private company operating as a specialized supplier in the molecular biology tools and diagnostics sector. It develops and distributes a range of proprietary products, including the Adenylator™ kit, Phi29™ Polymerase, and various qPCR and FISH-based detection kits, primarily serving research and diagnostic laboratories. The company's strategy centers on providing high-performance, often enzyme-based, reagents that offer advantages over standard methods, positioning it in the competitive life science tools market. Its deep integration into the research supply chain is evidenced by its network of distributors and suppliers.

Expertise in enzymology and molecular assay development for research and diagnostics, focusing on high-performance enzymes (e.g., Phi29 polymerase, Cap-Clip), optimized reagent kits (e.g., Adenylator, qPCR master mixes), and validated detection/QC assays (e.g., FISH probes, mycoplasma tests).

Operates in the highly competitive life science tools and diagnostics market, competing against global giants like Thermo Fisher Scientific and Merck KGaA, as well as many specialized reagent companies. Cambio differentiates through a focused portfolio of proprietary, performance-advantaged enzymes and kits, and by catering to specific QC and compliance needs in regulated environments.